Cargando…
The Cooling Effect on Proinflammatory Cytokines Interferon-Gamma, Tumor Necrosis Factor-Alpha, and Nitric Oxide in Patients with Multiple Sclerosis
Multiple sclerosis (MS) is the most common inflammatory demyelinating disease of the central nervous system (CNS) in young adults. The proinflammatory cytokines such as interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), and nitric oxide (NO) which are known to be produced by inflammatory...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671506/ https://www.ncbi.nlm.nih.gov/pubmed/23762603 http://dx.doi.org/10.1155/2013/964572 |
_version_ | 1782271993759924224 |
---|---|
author | Poyraz, Turan Idiman, Egemen Uysal, Sezer Iyilikci, Leyla Özakbaş, Serkan Coskuner Poyraz, Esra Idiman, Fethi |
author_facet | Poyraz, Turan Idiman, Egemen Uysal, Sezer Iyilikci, Leyla Özakbaş, Serkan Coskuner Poyraz, Esra Idiman, Fethi |
author_sort | Poyraz, Turan |
collection | PubMed |
description | Multiple sclerosis (MS) is the most common inflammatory demyelinating disease of the central nervous system (CNS) in young adults. The proinflammatory cytokines such as interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), and nitric oxide (NO) which are known to be produced by inflammatory cells play a key role in the pathogenesis of MS. Some metabolic changes may have an effect on axonal transmission, and white blood cells NO and other inflammatory mediators such as cytokines may be affected from cooling process. In this study, we evaluated the effects of body cooling procedure on proinflammatory cytokines such as TNF-α, IFN-γ, and NO levels. Twenty patients with MS were evaluated. Thirteen of the patients were women, 7 were men (mean age: 33.6 ± 7.5 yrs.). Body temperature was reduced by an average of 1°C approximately in 1 hour with using the “Medivance Arctic Sun Temperature Management System” device. In our study, the decrease in TNF-α, IFN-γ levels after the cooling procedure has no statistical significance, whereas the decrease in the mean level of NO level after the cooling procedure is 4.63 ± 7.4 μmol/L which has statistical significance (P = 0.002). These results suggested that the decrease in NO level improves conduction block in demyelinated axonal segments after cooling procedure in multiple sclerosis. |
format | Online Article Text |
id | pubmed-3671506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-36715062013-06-12 The Cooling Effect on Proinflammatory Cytokines Interferon-Gamma, Tumor Necrosis Factor-Alpha, and Nitric Oxide in Patients with Multiple Sclerosis Poyraz, Turan Idiman, Egemen Uysal, Sezer Iyilikci, Leyla Özakbaş, Serkan Coskuner Poyraz, Esra Idiman, Fethi ISRN Neurol Clinical Study Multiple sclerosis (MS) is the most common inflammatory demyelinating disease of the central nervous system (CNS) in young adults. The proinflammatory cytokines such as interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), and nitric oxide (NO) which are known to be produced by inflammatory cells play a key role in the pathogenesis of MS. Some metabolic changes may have an effect on axonal transmission, and white blood cells NO and other inflammatory mediators such as cytokines may be affected from cooling process. In this study, we evaluated the effects of body cooling procedure on proinflammatory cytokines such as TNF-α, IFN-γ, and NO levels. Twenty patients with MS were evaluated. Thirteen of the patients were women, 7 were men (mean age: 33.6 ± 7.5 yrs.). Body temperature was reduced by an average of 1°C approximately in 1 hour with using the “Medivance Arctic Sun Temperature Management System” device. In our study, the decrease in TNF-α, IFN-γ levels after the cooling procedure has no statistical significance, whereas the decrease in the mean level of NO level after the cooling procedure is 4.63 ± 7.4 μmol/L which has statistical significance (P = 0.002). These results suggested that the decrease in NO level improves conduction block in demyelinated axonal segments after cooling procedure in multiple sclerosis. Hindawi Publishing Corporation 2013-05-16 /pmc/articles/PMC3671506/ /pubmed/23762603 http://dx.doi.org/10.1155/2013/964572 Text en Copyright © 2013 Turan Poyraz et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Poyraz, Turan Idiman, Egemen Uysal, Sezer Iyilikci, Leyla Özakbaş, Serkan Coskuner Poyraz, Esra Idiman, Fethi The Cooling Effect on Proinflammatory Cytokines Interferon-Gamma, Tumor Necrosis Factor-Alpha, and Nitric Oxide in Patients with Multiple Sclerosis |
title | The Cooling Effect on Proinflammatory Cytokines Interferon-Gamma, Tumor Necrosis Factor-Alpha, and Nitric Oxide in Patients with Multiple Sclerosis |
title_full | The Cooling Effect on Proinflammatory Cytokines Interferon-Gamma, Tumor Necrosis Factor-Alpha, and Nitric Oxide in Patients with Multiple Sclerosis |
title_fullStr | The Cooling Effect on Proinflammatory Cytokines Interferon-Gamma, Tumor Necrosis Factor-Alpha, and Nitric Oxide in Patients with Multiple Sclerosis |
title_full_unstemmed | The Cooling Effect on Proinflammatory Cytokines Interferon-Gamma, Tumor Necrosis Factor-Alpha, and Nitric Oxide in Patients with Multiple Sclerosis |
title_short | The Cooling Effect on Proinflammatory Cytokines Interferon-Gamma, Tumor Necrosis Factor-Alpha, and Nitric Oxide in Patients with Multiple Sclerosis |
title_sort | cooling effect on proinflammatory cytokines interferon-gamma, tumor necrosis factor-alpha, and nitric oxide in patients with multiple sclerosis |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671506/ https://www.ncbi.nlm.nih.gov/pubmed/23762603 http://dx.doi.org/10.1155/2013/964572 |
work_keys_str_mv | AT poyrazturan thecoolingeffectonproinflammatorycytokinesinterferongammatumornecrosisfactoralphaandnitricoxideinpatientswithmultiplesclerosis AT idimanegemen thecoolingeffectonproinflammatorycytokinesinterferongammatumornecrosisfactoralphaandnitricoxideinpatientswithmultiplesclerosis AT uysalsezer thecoolingeffectonproinflammatorycytokinesinterferongammatumornecrosisfactoralphaandnitricoxideinpatientswithmultiplesclerosis AT iyilikcileyla thecoolingeffectonproinflammatorycytokinesinterferongammatumornecrosisfactoralphaandnitricoxideinpatientswithmultiplesclerosis AT ozakbasserkan thecoolingeffectonproinflammatorycytokinesinterferongammatumornecrosisfactoralphaandnitricoxideinpatientswithmultiplesclerosis AT coskunerpoyrazesra thecoolingeffectonproinflammatorycytokinesinterferongammatumornecrosisfactoralphaandnitricoxideinpatientswithmultiplesclerosis AT idimanfethi thecoolingeffectonproinflammatorycytokinesinterferongammatumornecrosisfactoralphaandnitricoxideinpatientswithmultiplesclerosis AT poyrazturan coolingeffectonproinflammatorycytokinesinterferongammatumornecrosisfactoralphaandnitricoxideinpatientswithmultiplesclerosis AT idimanegemen coolingeffectonproinflammatorycytokinesinterferongammatumornecrosisfactoralphaandnitricoxideinpatientswithmultiplesclerosis AT uysalsezer coolingeffectonproinflammatorycytokinesinterferongammatumornecrosisfactoralphaandnitricoxideinpatientswithmultiplesclerosis AT iyilikcileyla coolingeffectonproinflammatorycytokinesinterferongammatumornecrosisfactoralphaandnitricoxideinpatientswithmultiplesclerosis AT ozakbasserkan coolingeffectonproinflammatorycytokinesinterferongammatumornecrosisfactoralphaandnitricoxideinpatientswithmultiplesclerosis AT coskunerpoyrazesra coolingeffectonproinflammatorycytokinesinterferongammatumornecrosisfactoralphaandnitricoxideinpatientswithmultiplesclerosis AT idimanfethi coolingeffectonproinflammatorycytokinesinterferongammatumornecrosisfactoralphaandnitricoxideinpatientswithmultiplesclerosis |